Hydrocortisone Sodium Succinate BP 100 mg/2 ml

Business Unit: Human

Medicine Type: Injectable

Generic Name: Hydrocortisone Sodium Succinate BP 100 mg/2 ml

Therapeutic Class: Glucocorticoids

Indication: Hycort is an injectable preparation of Hydrocortisone BP which is a synthetic corticosteroid. Hydrocortisone is indicated for use in the following conditions: Primary or secondary adrenocortical insufficiency Acute adrenocortical insufficiency Shock unresponsive to conventional therapy Congenital adrenal hyperplasia Hypercalcemia associated with cancer Non-suppurative thyroiditis Rheumatic Disorders Dermatologic Diseases (Allergic States, Severe seborrheic dermatitis, Severe psoriasis, Pemphigus, Severe erythema multiforme) Control of severe or incapacitating allergic conditions (Bronchial asthma, Contact dermatitis, Atopic dermatitis, Serum sickness, Seasonal or perennial allergic rhinitis, Drug hypersensitivity reactions, Urticarial transfusion reactions, Acute noninfectious laryngeal edema) Ophthalmic Diseases (Herpes zoster ophthalmicus, Iritis, iridocyclitis, Chorioretinitis, Diffuse posterior uveitis and choroiditis, Optic neuritis) Gastrointestinal Diseases Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy Loeffler's syndrome Aspiration pneumonitis Hematologic Disorders (Acquired, autoimmune hemolytic anemia, Idiopathic thrombocytopenic purpura in adults, Secondary thrombocytopenia, Erythroblastopenia) Neoplastic Diseases (Leukemias and lymphomas in adults, Acute leukemia of childhood) Edematous States Acute exacerbations of multiple sclerosis

Dosage & Administration: Adult : by IM injection or slow IV injection or infusion, 100-500 mg, 3-4 times in 24 hours or as required. Child: by slow IV Injection, up to 1 year: 25 mg, 1-5 years: 50 mg, 6-12 years: 100 mg.

Preparation: 1 ml X 1 Injection.

•